Search clinical trials for: SNDX-275
Total 2912 results
-
Syndax PharmaceuticalsCompletedHealthy Volunteer | Drug InteractionUnited States
-
Roberto PiliGenentech, Inc.; Syndax PharmaceuticalsSuspendedMetastatic Cancer | Renal CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Invasive Breast Carcinoma | HER2/Neu Positive | Stage IV Breast Cancer AJCC v6 and v7United States
-
Kyowa Kirin Co., Ltd.Completed
-
Bristol-Myers SquibbCompletedImmune Thrombocytopenic PurpuraUnited States, Australia, United Kingdom, Canada, Georgia, Moldova, Republic of, Poland, Russian Federation
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Breast AdenocarcinomaUnited States
-
University of Maryland, BaltimoreSyndax PharmaceuticalsTerminatedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Triple-negative Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | HER2/Neu Negative | Breast Adenocarcinoma | Metastatic Breast Carcinoma | Locally Advanced Breast CarcinomaUnited States, South Africa
-
Syndax PharmaceuticalsCompleted
-
National Cancer Institute (NCI)Completed
-
Esanex Inc.Serenex, Inc.CompletedHematologic NeoplasmsUnited States
-
Loci OrthopaedicsNorth American Science Associates Ltd.Active, not recruitingOsteoarthritis Thumb Base JointBelgium
-
Syndax PharmaceuticalsCompletedBreast Cancer | ER+ Breast Cancer | Estrogen Receptor-Positive Breast Cancer | Breast Cancer, Estrogen Receptor-PositiveUnited States, Czechia, Canada, Hungary, Russian Federation
-
Hepion Pharmaceuticals, Inc.Active, not recruitingNASH With FibrosisUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterAbbVie; Syndax Pharmaceuticals; Break Through CancerNot yet recruiting
-
Syndax PharmaceuticalsCompletedSolid Tumor | Unresectable Malignant Neoplasm | Locally Advanced Malignant Neoplasm | Metastatic TumorUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...AstraZeneca; Syndax PharmaceuticalsCompletedUnresectable Intrahepatic CholangiocarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingClear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Metastatic Kidney CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterSynDevRx, Inc.RecruitingBreast Cancer | Metastatic Triple-Negative Breast CancerUnited States
-
Syndax PharmaceuticalsRecruitingAcute Myeloid LeukemiasUnited States
-
Eisai Inc.Completed
-
Otsuka Frankfurt Research Institute GmbHCompletedPulmonary TuberculosisSouth Africa
-
Global Alliance for TB Drug DevelopmentCompletedPulmonary TuberculosisSouth Africa
-
Esanex Inc.TerminatedCancerUnited States
-
Esanex Inc.National Cancer Institute (NCI)CompletedLymphoma | Leukemia | Solid Tumor Malignancy | Lymphoid Malignancy (Lymphoma and CLL)United States
-
Esanex Inc.Completed
-
Esanex Inc.Completed
-
Esanex Inc.Pfizer; Serenex, Inc.Completed
-
NexEos Diagnostics, Inc.RecruitingEosinophilic EsophagitisUnited States
-
Global Alliance for TB Drug DevelopmentCompletedPulmonary Tuberculosis
-
Zevra TherapeuticsRho, Inc.Active, not recruitingIdiopathic HypersomniaUnited States
-
University of PittsburghCompletedDepression | Inflammatory Bowel DiseaseUnited States
-
National Cancer Institute (NCI)TerminatedBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Hormone Receptor Negative Breast Cancer | HER2+ Breast CancerUnited States
-
Janssen Research & Development, LLCCompletedAge-related Macular DegenerationUnited States
-
Novartis PharmaceuticalsCompleted
-
PfizerCompleted
-
Instituto Valenciano de Infertilidad, IVI VALENCIACompleted
-
EMD SeronoMerck KGaA, Darmstadt, GermanyTerminatedRelapsing Multiple SclerosisSweden, United States, Czech Republic, Russian Federation, Spain, United Kingdom, Lithuania, Ukraine, Netherlands, Canada, Germany, France, Switzerland, Australia, Belgium, Lebanon, New Caledonia
-
George Washington UniversityTerminatedProstate AdenocarcinomaUnited States
-
Alto NeuroscienceRecruitingAnhedonia | Major Depressive DisorderUnited States
-
Syndax PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Lymphocytic Leukemia | Acute Undifferentiated Leukemia | Relapsed/Refractory Leukemias | Mixed Phenotype Acute LeukemiaUnited States, Canada
-
Esanex Inc.Terminated
-
Esanex Inc.Completed
-
M.D. Anderson Cancer CenterAstex Pharmaceuticals, Inc.; Syndax PharmaceuticalsRecruiting
-
PHARMENTERPRISES LLCNot yet recruitingStudy to Evaluate the Efficacy and Safety of XC243 in Patients With Exacerbation of Chronic CystitisCystitisRussian Federation